Non-Hodgkin's Lymphoma Clinical Trials

A listing of Non-Hodgkin's Lymphoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

University of Alabama at Birmingham
Birmingham Alabama 35294

A clinical trial for people with newly diagnosed ALCL (Anaplastic Large Cell Lymphoma), a type of non-Hodgkin (T-cell) lymphoma

View More ▼

UPDATED

Birmingham Alabama 35213

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Huntsville Alabama 35805

A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma

UPDATED

Mobile Alabama 36608

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

Birmingham Alabama 35233

A Phase 1 clinical study for patients with Lymphoma, B-Cell, Non-Hodgkin's Lymphoma

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Daphne Alabama 36526

A Phase 3 clinical study for patients with Follicular Lymphoma

Huntsville Alabama 35805

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36608

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36607

A Phase 3 clinical study for patients with Follicular Lymphoma

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of Rituximab, Lenalidomide and Placebo to evaluate Lymphoma, Non-Hodgkin

Arizona

Banner MD Anderson Cancer Center
Gilbert Arizona 85234

A clinical trial for people with newly diagnosed ALCL (Anaplastic Large Cell Lymphoma), a type of non-Hodgkin (T-cell) lymphoma

View More ▼

UPDATED

Chandler Arizona 85224

A Phase 2 clinical study for patients with Lymphoma, Non-Hodgkin

UPDATED

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Lymphoma, Follicular

UPDATED

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of GDC-0032, letrozole and fulvestrant to evaluate Solid Cancers

UPDATED

Tucson Arizona 85719

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

UPDATED

Tucson Arizona 85715

Patients are needed to participate in a clinical research study of Ofatumumab and Bendamustine infusions (Arm A) and Bendamustine infusion (Arm B) to evaluate Lymphoma, Follicular

Scottsdale Arizona 85259-5499

A clinical trial seeking patients for a research study of CB-839 for the treatment of Hematological Tumors

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tucson Arizona 85710

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

Tucson Arizona 85715

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85745

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Arkansas

Bentonville Arkansas 72712

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Fayetteville Arkansas 72703

A clinical research study of Pixantrone + Rituximab and Gemcitabine + Rituximab for the treatment of Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma or Follicular Grade 3 Lymphoma

Jonesboro Arkansas 72401

A clinical research study of Ublituximab + TGR-1202 for the treatment of Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma

Little Rock Arkansas 72205

A clinical research study of Lenalidomide and Rituximab for the treatment of Lymphoma, Non-Hodgkin

California

City of Hope National Medical Center
Duarte California 91010-3000

A clinical trial for people with newly diagnosed ALCL (Anaplastic Large Cell Lymphoma), a type of non-Hodgkin (T-cell) lymphoma

Stanford Cancer Center
Stanford California 94305

A clinical trial for people with newly diagnosed ALCL (Anaplastic Large Cell Lymphoma), a type of non-Hodgkin (T-cell) lymphoma

View More ▼

UPDATED

Anaheim California 90801

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Duarte California 91010

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

UPDATED

Greenbrae California 94904

A Phase 1 clinical study for patients with Non-Hodgkin's Lymphoma

UPDATED

Greenbrae California 94904

A Phase 3 clinical study for patients with Lymphoma, Follicular

UPDATED

La Jolla California 92037-0845

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

La Jolla California 92037-0845

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

La Jolla California 92093

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

La Jolla California 92093

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

UPDATED

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Lymphoma, Non-Hodgkin

UPDATED

Los Angeles California 90027

A clinical trial to evaluate treatments for patients with Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma or Peripheral T-cell Lymphoma

UPDATED

Los Angeles California 90095

A Phase 1 clinical study for patients with Non-Hodgkin's Lymphoma

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

UPDATED

Monterey California 93940

A Phase 3 clinical study for patients with Lymphoma, Follicular

UPDATED

Palo Alto California 94304

Patients are needed to participate in a clinical research study of Urelumab and Nivolumab to evaluate Advanced Solid Tumors or Advanced B-cell Non-Hodgkins Lymphoma (NHL)